Teachey, David T.
Hunger, Stephen P.
Article History
First Online: 19 December 2017
Competing interests
: D.T.T. has served on an advisory board for Amgen and received research funding from Novartis. S.P.H. owns stock in Amgen, Merck, and Pfizer, and has received honoraria from Amgen, Erytech, Jazz Pharmaceuticals, and Spectrum Pharmaceuticals, and consulting fees from Novartis.